| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | Yu K Peony | Chief Medical Officer | Sell | 3,350 | $41.61 | $139,393.50 | -1.7% | |
| Dec 15, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,068 | $43.60 | $133,764.80 | -1.1% | |
| Sep 16, 2020 | Yu K Peony | Chief Medical Officer | Sell | 3,351 | $44.01 | $147,477.51 | -1.7% | |
| Sep 15, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,070 | $43.63 | $133,944.10 | -1.1% | |
| Sep 3, 2020 | Yu K Peony | Chief Medical Officer | Sale+OE | 10,000 | $50.89 | $508,900.00 | -4.6% | |
| Sep 3, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 15,004 | $50.91 | $763,853.64 | -5.1% | |
| Aug 7, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 22,554 | $48.00 | $1,082,592.00 | -7.7% | |
| Jul 24, 2020 | Yu K Peony | Chief Medical Officer | Sell | 3,351 | $42.35 | $141,914.85 | -1.6% | |
| Jun 16, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,928 | $39.68 | $155,863.04 | -1.4% | |
| Jun 11, 2020 | Conterno Enrique A87 | Chief Executive Officer | Buy | 27,800 | $35.57 | $988,881.84 | +347.5% |